For instance, a mutation in the MLH1 gene associated with a lower risk of endometrial and extracolonic cancers has been identified in the Danish population [75] while an MLH1 founder mutation associated with an aggressive phenotype and extracolonic manifestations has been described in Southern Italy [12]. This evidence concerns the gene MLH1 and cancer.